JP2024502170A5 - - Google Patents

Info

Publication number
JP2024502170A5
JP2024502170A5 JP2023541633A JP2023541633A JP2024502170A5 JP 2024502170 A5 JP2024502170 A5 JP 2024502170A5 JP 2023541633 A JP2023541633 A JP 2023541633A JP 2023541633 A JP2023541633 A JP 2023541633A JP 2024502170 A5 JP2024502170 A5 JP 2024502170A5
Authority
JP
Japan
Prior art keywords
cells
cell
tumor
cell composition
sak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541633A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2022/050038 external-priority patent/WO2022153295A1/en
Publication of JP2024502170A publication Critical patent/JP2024502170A/ja
Publication of JP2024502170A5 publication Critical patent/JP2024502170A5/ja
Pending legal-status Critical Current

Links

JP2023541633A 2021-01-12 2022-01-11 癌のための改良された養子細胞移植療法 Pending JP2024502170A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163136217P 2021-01-12 2021-01-12
US63/136,217 2021-01-12
PCT/IL2022/050038 WO2022153295A1 (en) 2021-01-12 2022-01-11 Improved adoptive cell transfer therapy for cancer

Publications (2)

Publication Number Publication Date
JP2024502170A JP2024502170A (ja) 2024-01-17
JP2024502170A5 true JP2024502170A5 (https=) 2024-11-06

Family

ID=82447153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541633A Pending JP2024502170A (ja) 2021-01-12 2022-01-11 癌のための改良された養子細胞移植療法

Country Status (5)

Country Link
US (1) US20240307536A1 (https=)
EP (1) EP4277638A4 (https=)
JP (1) JP2024502170A (https=)
IL (1) IL304373A (https=)
WO (1) WO2022153295A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121378506A (zh) * 2025-10-21 2026-01-23 北京京科信拓生物技术有限公司 表达car的免疫细胞及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009097119A2 (en) * 2008-01-29 2009-08-06 Fred Hutchinson Cancer Research Center Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity
CN102428173B (zh) * 2009-03-26 2014-07-30 细胞维护北欧制药公司 Nk细胞的扩增
AU2021286655A1 (en) * 2020-06-12 2023-01-05 Nkarta, Inc. Genetically modified natural killer cells for CD70-directed cancer immunotherapy

Similar Documents

Publication Publication Date Title
JP7527049B2 (ja) Ｃａｒ発現ベクター及びｃａｒ発現ｔ細胞
US20250109180A1 (en) Immunomodulatory fusion proteins and uses thereof
KR102483822B1 (ko) 태그된 키메라 이펙터 분자 및 그의 리셉터
JP7696658B2 (ja) ヒトメソセリンを特異的に認識する細胞表面分子、ｉｌ－７、及びｃｃｌ１９を発現する免疫担当細胞
JP2022113880A (ja) 免疫調節性融合タンパク質およびその使用
JP6985934B2 (ja) 操作された造血幹細胞／前駆細胞及び非ｔエフェクター細胞、ならびにその使用
ES2995785T3 (en) Gene therapy
JP2019536452A (ja) 融合タンパク質を用いたｔｃｒの再プログラミングのための組成物及び方法
US20170313759A1 (en) Novel chimeric antigen receptors
CN108137670A (zh) Ny-eso-1特异性tcr及其使用方法
KR20180012754A (ko) 변형된 감마 델타 t 세포 및 이의 용도
KR20140023931A (ko) 세포 면역요법용 방법 및 조성물
US20210379149A1 (en) Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell Therapy
JP2022512450A (ja) Ｇｐｃ３を標的とする免疫エフェクター細胞およびその応用
WO2022232277A1 (en) COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS AND TGFβR SWITCH
JP6842688B2 (ja) キメラ抗原受容体
US20240307536A1 (en) Improved adoptive cell transfer therapy for cancer
JP2024502170A5 (https=)
JP7054181B2 (ja) キメラ抗原受容体
Biondi Enhancing AML CAR CIK therapeutic potency increasing the localization of engineered cells in the malignant niche and its selectivity by LSCs specific targeting
WO2025224123A1 (en) Chimeric antigen receptors specific for fibroblast activation protein
HK1235426B (en) Car expression vector and car-expressing t cells